Company Biondvax Pharmaceuticals Ltd Other OTC
Equities
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 49 | 21-03-01 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 06-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-12-31 | |
Shai Ashkenazi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Elad Mark
COO | Chief Operating Officer | 42 | 17-12-31 |
Shimon Hassin
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 03-12-31 | |
Investor Relations Contact | - | 15-11-30 | |
Human Resources Officer | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adi Raviv
BRD | Director/Board Member | 69 | 20-03-23 |
Samuel Moed
BRD | Director/Board Member | 62 | 20-03-23 |
Morris Laster
BRD | Director/Board Member | 60 | 17-11-26 |
Mark Germain
CHM | Chairman | 75 | 18-06-27 |
Yael Margolin
BRD | Director/Board Member | 70 | 18-12-31 |
Avner Rotman
BRD | Director/Board Member | 80 | 05-03-26 |
Amir Reichman
CEO | Chief Executive Officer | 49 | 21-03-01 |
Jay Green
BRD | Director/Board Member | 52 | 21-12-26 |
Company contact information
Scinai Immunotherapeutics Ltd.
Jerusalem BioPark Hadassah Ein Kerem Campus
74036, Jerusalem
+972 8 930 2529
http://www.biondvax.comSector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |